Joaquı́n Mateo

Also affiliated with Universitat Autònoma de Barcelona, Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Delivering precision oncology to patients with cancer”.

Delivering precision oncology to patients with cancer

Nature Medicine(2022)10.1038/s41591-022-01717-2

N/A

0.885DataRank · unranked

365 citations

Lotte Steuten, Philippe Aftimos, Fabrice Andre, Mark Davies, Elena Garralda +10 more

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

Cancer Research(2022)10.1158/0008-5472.can-21-2409

N/A

0DataRank · unranked

98 citations

Andrea Herencia-Ropero, Alba Llop‐Guevara, Flaminia Pedretti, Alejandro Moles‐Fernández, Cristina Viaplana +34 more

Data from Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

(2023)10.1158/0008-5472.c.6513876.v1

N/A

0DataRank · unranked

0 citations

Andrea Herencia-Ropero, Alba Llop‐Guevara, Flaminia Pedretti, Alejandro Moles‐Fernández, Cristina Viaplana +34 more

A multi-center natural history study of precision-based genomics in prostate cancer (PC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5121

N/A

0DataRank · unranked

0 citations

Joaquı́n Mateo, Wassim Abida, Rana R. McKay, Bruce Montgomery, Rahul Aggarwal +5 more

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European Urology(2021)10.1016/j.eururo.2020.12.037

N/A

0DataRank · unranked

94 citations

Alejandro Athie, Paul C. Boutros, Marzia Del Re, David T. Miyamoto, Kenneth J. Pienta +6 more

Heterogeneity of the Treatment Effect with PARP Inhibitors in Metastatic Castration-resistant Prostate Cancer: A Living Interactive Systematic Review and Meta-analysis

European Urology(2025)10.1016/j.eururo.2024.12.007

N/A

0DataRank · unranked

36 citations

Irbaz Bin Riaz, Arifa Bibi, Muhammad Ali Khan, Manal Imran, Kaneez Zahra Rubab Khakwani +16 more

Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis

European Urology Oncology(2025)10.1016/j.euo.2025.04.015

N/A

0DataRank · unranked

0 citations

Rebecca S. Tidwell, Brian F. Chapin, Deborah Harris, Miao Zhang, Louis L. Pisters +11 more

Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.011

N/A

0DataRank · unranked

8 citations

Wassim Abida, Emmanuel S. Antonarakis, Alan H. Bryce, Elena Castro, Heather H. Cheng +3 more